CIK 0001585364 · Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-06 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −612 | $28.09 | $17K | 16,790 |
| 2024-03-06 | Ives Alison EVP & Chief Scientific Officer | Option exercise · Restricted Stock Units | −2,030 | 4,058 | ||
| 2024-03-06 | Andersen Svend EVP & President CHCI | Option exercise | +3,788 | $28.09 | $106K | 95,385 |
| 2024-03-06 | Andersen Svend EVP & President CHCI | Option exercise · Restricted Stock Units | −3,788 | 7,576 | ||
| 2024-03-05 | Ives Alison EVP & Chief Scientific Officer | Option exercise | +1,698 | $27.26 | $46K | 14,144 |
| 2024-03-05 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −512 | $27.26 | $14K | 13,632 |
| 2024-03-05 | Ives Alison EVP & Chief Scientific Officer | Purchase | +2,490 | $27.26 | $68K | 16,122 |
| 2024-03-05 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −750 | $27.26 | $20K | 15,372 |
| 2024-03-05 | Ives Alison EVP & Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,698 | 0 | ||
| 2024-03-05 | Janish Ronald Craig EVP, Gbl Ops & SC & CTO | Option exercise | +2,071 | $27.26 | $56K | 22,262 |
| 2024-03-05 | Janish Ronald Craig EVP, Gbl Ops & SC & CTO | Shares withheld for taxes | −624 | $27.26 | $17K | 21,638 |
| 2024-03-05 | Janish Ronald Craig EVP, Gbl Ops & SC & CTO | Grant or award | +11,806 | $27.26 | $322K | 33,444 |
| 2024-03-05 | Janish Ronald Craig EVP, Gbl Ops & SC & CTO | Shares withheld for taxes | −3,554 | $27.26 | $97K | 29,890 |
| 2024-03-05 | Janish Ronald Craig EVP, Gbl Ops & SC & CTO | Option exercise · Restricted Stock Units | −2,071 | 0 | ||
| 2024-03-05 | Willis Robert EVP & CHRO | Option exercise | +1,279 | $27.26 | $35K | 26,755 |
| 2024-03-05 | Willis Robert EVP & CHRO | Shares withheld for taxes | −666 | $27.26 | $18K | 26,089 |
| 2024-03-05 | Willis Robert EVP & CHRO | Grant or award | +7,291 | $27.26 | $199K | 33,380 |
| 2024-03-05 | Willis Robert EVP & CHRO | Shares withheld for taxes | −3,792 | $27.26 | $103K | 29,588 |
| 2024-03-05 | Willis Robert EVP & CHRO | Option exercise · Restricted Stock Units | −1,279 | 0 | ||
| 2024-03-05 | Quinn Grainne EVP, Chief Medical Officer | Option exercise | +1,583 | $27.26 | $43K | 15,646 |
Page 20 of 27 · 524 trades